Antibody responses against V3 and gp120 epitopes did not increase following vaccination and were significantly lower than those induced by HIV-infection, which is in stark contrast to prior trials of HIV-1 Env protein subunit vaccines.7 Here, ERVW-1 is linked to HIV infectious disease.